Safety Study of CD-NP in Heart Failure

NCT00557661 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: CD-NP

Sponsor

Nile Therapeutics